ISHITA DRUGS & INDUSTRIES LTD. Share Price
ISHITA DRUGS & INDUSTRIES LTD. Returns Calculator
About ISHITA DRUGS & INDUSTRIES LTD.
Ishita Drugs and Industries Limited is a manufacturer of various active pharma ingredients (APIs) (bulk actives and their salts), drug intermediates, excipients, and fine chemicals. The Company's APIs include sulpha drugs/sulfonamides, vitamins, fluoroquinolones, antibiotics, anthelmintics, iodides and citrates (salts), food additive/excipients, and others. Its drug intermediates include 4- Sulfonamido Phenyl Hydrazine Hydrochloride (Celecoxib Intermediate), 4- Chloro Phenyl Hydrazine Hydrochloride (intermediate for Indole Carboxylic Acid), L-Alanine Benzylester Tosylate, 5 Cyano Phthalide (Citalopram Intermediate), Indole 2 Carboxylic Acid, Ethyl 3-Benzoyl Acrylate, Hexa Methyl Disilazane, 5-Chloromethopabate, and others. Its fine chemicals include salicylanilide, para bromo toluene, pyridine hydrobromide, potassium phthalimide, nicotinic acid hydrazide, 3 amino pyridine, and methyl iodide. The Company has three manufacturing facilities located in the state of Gujarat.
ISHITA DRUGS & INDUSTRIES LTD. Financial Highlights
- Revenue: ISHITA DRUGS & INDUSTRIES LTD. reported revenue of ₹15.13 crore in FY26 vs ₹15.34 crore in FY25. It showed a decrease of 1.37% on a yearly basis.
- Operating Profit: ISHITA DRUGS & INDUSTRIES LTD. reported an operating profit of ₹1.08 crore in FY26 vs ₹1.16 crore in FY25. It showed a decrease of 6.90% on a year-on-year basis.
- Net Profit: ISHITA DRUGS & INDUSTRIES LTD. reported a net profit of ₹0.78 crore in FY26 vs ₹0.87 crore in FY25. It showed a decrease of 10.34% on a yearly basis.
ISHITA DRUGS & INDUSTRIES LTD. Quarterly Result Highlights
- ISHITA DRUGS & INDUSTRIES LTD. reported revenue of ₹3.19 crore in Jun 2026, compared with ₹3.28 crore in Mar 2026, representing a decrease of 2.74% on a quarter-on-quarter (QoQ) basis.
- ISHITA DRUGS & INDUSTRIES LTD. reported an operating profit of ₹0.30 crore in Jun 2026, compared with ₹0.28 crore in Mar 2026, representing an increase of 7.14% on a quarter-on-quarter (QoQ) basis.
- ISHITA DRUGS & INDUSTRIES LTD. reported a profit of ₹0.23 crore in Jun 2026, compared with ₹0.18 crore in Mar 2026, reflecting an increase of 27.78% on a QoQ basis.
- The earnings per share (EPS) of ISHITA DRUGS & INDUSTRIES LTD. stood at ₹2.90 during Jun 2026.
| Sep 2025 | 0.00% |
|---|---|
| Dec 2025 | 0.00% |
| Mar 2026 | 0.00% |
| Jun 2026 | 0.00% |
ISHITA DRUGS & INDUSTRIES LTD. Shareholder Returns
ISHITA DRUGS & INDUSTRIES LTD. Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,63,791.00 | 38.28 | 5.55 | 13.74% | 0.61 | 17.33% | 93.24 | 0.83% | 0.48 | 10.90 |
| Divis Laboratories | 2,45,081.00 | 83.79 | 14.62 | 15.32% | 0.00 | 19.56% | 629.49 | 0.32% | 0.55 | 98.19 |
| Torrent Pharmaceuticals | 1,90,351.00 | 88.29 | 22.64 | 25.49% | 1.69 | 13.85% | 222.76 | 0.68% | 0.49 | 58.70 |
| Zydus Lifesciences | 1,16,114.00 | 25.00 | 4.24 | 18.59% | 0.31 | 17.35% | 237.30 | 0.09% | 0.33 | 35.38 |
| Cipla | 1,14,554.00 | 34.02 | 3.32 | 11.27% | 0.00 | 14.95% | 423.36 | 0.92% | 0.45 | 43.52 |
| Laurus Labs | 1,00,660.00 | 92.32 | 18.99 | 16.77% | 0.40 | 16.14% | 97.20 | 0.11% | 0.67 | 13.72 |
| Lupin | 98,312.20 | 17.73 | 4.38 | 23.76% | 0.04 | 24.88% | 659.00 | 0.84% | 0.57 | 129.18 |
| Dr. Reddy's Laboratories | 96,906.30 | 30.44 | 2.55 | 11.07% | 0.18 | 12.54% | 377.95 | 0.69% | 0.41 | 38.68 |
| Mankind Pharma | 97,467.00 | 47.54 | 6.03 | 11.74% | 0.34 | 13.13% | 397.02 | 0.04% | 0.44 | 49.37 |
| Aurobindo Pharma | 95,299.80 | 25.68 | 2.52 | 9.25% | 0.19 | 11.76% | 394.82 | 0.24% | 0.38 | 41.58 |
ISHITA DRUGS & INDUSTRIES LTD. Financials
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹15.00 | ₹15.19 | ₹12.07 | ₹14.09 |
| Other Income | ₹0.34 | ₹0.28 | ₹0.20 | ₹0.11 |
| Total Revenue | ₹15.33 | ₹15.47 | ₹12.27 | ₹14.20 |
| Total Expenses | ₹14.18 | ₹14.48 | ₹11.49 | ₹13.15 |
| Profit Before Tax | ₹1.16 | ₹0.99 | ₹0.78 | ₹1.04 |
| Tax | ₹0.29 | ₹0.24 | ₹0.20 | ₹0.24 |
| Profit After Tax | ₹0.87 | ₹0.75 | ₹0.58 | ₹0.80 |
| EPS - Basic | ₹2.90 | ₹2.50 | ₹1.93 | ₹2.69 |
| EPS - Diluted | ₹2.90 | ₹2.50 | ₹1.93 | ₹2.69 |
Cash Flow · Standalone
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Profit before tax | ₹1.08 | ₹1.16 | ₹0.99 | ₹0.78 |
| Income before WC changes | ₹0.80 | ₹1.00 | ₹0.91 | ₹0.76 |
| Change in Assets | ₹3.89 | -₹4.86 | ₹1.84 | -₹2.07 |
| Change in Liabilities | -₹0.77 | ₹0.22 | -₹0.63 | -₹1.59 |
| Change in WC | ₹3.12 | -₹4.64 | ₹1.21 | -₹3.66 |
| Cash flow from Operations | ₹3.92 | -₹3.64 | ₹2.12 | -₹2.90 |
| Cash flow from Investing | -₹2.24 | -₹0.67 | ₹0.13 | ₹0.59 |
| Cash flow from Financing | -₹3.81 | ₹4.33 | -₹0.87 | ₹1.05 |
| Total Cash Flow | -₹2.13 | ₹0.02 | ₹1.38 | -₹1.25 |
| Cash (Start of the year) | ₹4.83 | ₹4.81 | ₹3.43 | ₹4.68 |
| Cash (End of the year) | ₹2.70 | ₹4.83 | ₹4.81 | ₹3.43 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹1.31 | ₹1.15 | ₹1.23 | ₹1.21 |
| Current Assets | ₹14.98 | ₹9.66 | ₹10.18 | ₹10.05 |
| Total Assets | ₹16.30 | ₹10.81 | ₹11.41 | ₹11.25 |
| Current Liabilities | ₹5.40 | ₹0.87 | ₹2.21 | ₹2.63 |
| Net Current Asset | ₹9.58 | ₹8.79 | ₹7.96 | ₹7.42 |
| Non-Current Liabilities | ₹0.10 | ₹0.02 | ₹0.02 | ₹0.03 |
| Equity Capital | ₹10.79 | ₹9.92 | ₹9.17 | ₹8.60 |
| Total Equity & Liabilities | ₹16.30 | ₹10.81 | ₹11.41 | ₹11.25 |
| 1 Sep | 0L |
|---|---|
| 31 Aug | 0L |
| 28 Aug | 0L |
| 27 Aug | 0L |
| Average | 0L |
Popular Stocks
ISHITA DRUGS & INDUSTRIES LTD. Share Price FAQs
What is ISHITA DRUGS & INDUSTRIES LTD. share price today?
ISHITA DRUGS & INDUSTRIES LTD. share price is ₹71.90 as on 01 Sep, 2026, 15:27 IST.
How much is the Mutual Fund shareholding in ISHITA DRUGS & INDUSTRIES LTD. shares?
The Mutual Fund Shareholding in ISHITA DRUGS & INDUSTRIES LTD. was 0.00% at the end of Jun 2026.
What is the the 52-week high and low of ISHITA DRUGS & INDUSTRIES LTD. shares ?
The 52-week high and low of ISHITA DRUGS & INDUSTRIES LTD. share is ₹90.85 and ₹66.00 as of 01 Sep, 2026.
What is the market cap of ISHITA DRUGS & INDUSTRIES LTD.?
The market capitalisation of ISHITA DRUGS & INDUSTRIES LTD. is ₹21.50 Crores as on 01 Sep, 2026.
What are the stock symbols of ISHITA DRUGS & INDUSTRIES LTD.?
The stock symbol of ISHITA DRUGS & INDUSTRIES LTD. is 524400 on the BSE, and the ISIN is INE806D01016.
What was yesterday's closing price for ISHITA DRUGS & INDUSTRIES LTD. shares ?
ISHITA DRUGS & INDUSTRIES LTD. shares closed yesterday at ₹71.89 on BSE
How to buy ISHITA DRUGS & INDUSTRIES LTD. shares?
To buy ISHITA DRUGS & INDUSTRIES LTD. shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy ISHITA DRUGS & INDUSTRIES LTD. shares on Holidays?
No, shares of ISHITA DRUGS & INDUSTRIES LTD. or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell ISHITA DRUGS & INDUSTRIES LTD. shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of ISHITA DRUGS & INDUSTRIES LTD.?
The PE and PB ratio of ISHITA DRUGS & INDUSTRIES LTD. is 30.46 and 1.86 respectively, as on 01 Sep, 2026, 15:27 IST.